Insulin Sensitivity Index (ISI) is a quantitative measure derived from clinical data, often incorporating fasting glucose and insulin levels or dynamic testing, that reflects the efficiency with which peripheral tissues respond to circulating insulin. A high index indicates that lower insulin concentrations are required to achieve glucose disposal, signifying superior metabolic health. Conversely, a low ISI is a strong predictor of impending metabolic syndrome.
Origin
The ISI concept originates from quantitative glucose tolerance testing and the need to precisely assess the degree of insulin resistance in clinical endocrinology. It formalizes the relationship between insulin action and glucose homeostasis, providing a standardized metric for metabolic assessment. This index helps delineate pre-diabetic states accurately.
Mechanism
The index functions by mathematically relating the concentration of the signaling molecule (insulin) to the magnitude of the resulting biological effect (glucose uptake by muscle and fat cells). High fidelity in this signaling pathway means cellular GLUT4 transporters are readily mobilized upon insulin binding to the receptor. Improvements in ISI often correlate with enhanced mitochondrial function and reduced intramyocellular lipid accumulation.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.